Compare $OVID vs $PROK | Chartloom

Compare

$OVID vs $PROK

Ovid Therapeutics Inc · Prokidney Corp

OVID

Ovid Therapeutics Inc

PROK

Prokidney Corp

Compare $OVID vs $PROK

Comparing Ovid Therapeutics Inc and Prokidney Corp

OVIDOvid Therapeutics Inc

PROKProkidney Corp

OVIDOvid Therapeutics Inc

Market cap

$459M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

1,284.26x

Rev growth (TTM)

-76.2%

YTD performance

39.8%

52W performance

55.7%

FCF yield

-11.9%

PROKProkidney Corp

Market cap

$526M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

788.85x

Rev growth (TTM)

55.2%

YTD performance

-22.0%

52W performance

-46.6%

FCF yield

-30.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

OVID

PROK

Detailed metrics comparison

OVID

Ovid Therapeutics Inc

PROK

Prokidney Corp

Market Cap

OVID$459M

PROK$526M

Enterprise Value

OVID$448M

PROK$451M

Price

OVID$2.46

PROK$1.74

P/E Ratio

OVIDN/A

PROKN/A

P/S Ratio

OVID290.04x

PROK642.52x

EV/Sales

OVID282.89x

PROK551.08x

EV/EBITDA

OVID3.65x

PROK0.00x

P/B Ratio

OVID2.21x

PROK78.79x

P/FCF Ratio

OVIDN/A

PROKN/A

EV/FCF

OVID-8.18x

PROK-2.82x

PEG Ratio

OVIDN/A

PROKN/A

Forward P/E (NTM)

OVIDN/A

PROKN/A

Forward P/S (NTM)

OVID1,284.26x

PROK788.85x

Revenue (TTM)

OVID$2M

PROK$818K

Revenue Growth (YoY)

OVID-76.2%

PROK55.2%

Forward Rev Growth

OVID-72.6%

PROK-44.4%

Gross Margin (TTM)

OVID0.0%

PROK0.0%

Operating Margin (TTM)

OVID0.0%

PROK0.0%

EBITDA Margin (TTM)

OVID-3681.4%

PROK-20827.6%

Net Margin (TTM)

OVID-2178.9%

PROK-10288.4%

FCF Margin (TTM)

OVID-3460.1%

PROK-19527.4%

Net Income (TTM)

OVID$-34M

PROK$-84M

FCF (TTM)

OVID$-55M

PROK$-160M

EPS (TTM)

OVID-$0.17

PROK-$0.45

ROE (TTM)

OVID-2364.0%

PROK-2810.2%

ROA (TTM)

OVID-2052.0%

PROK-2739.0%

ROIC (TTM)

OVID-2364.0%

PROK0.0%

Cash

OVID$11M

PROK$75M

Debt

OVID$0

PROK$67K

Net Cash/Debt

OVID$11M

PROK$75M

Current Ratio (TTM)

OVID12.39x

PROK8.36x

Quick Ratio (TTM)

OVID11.75x

PROK8.07x

Debt/Equity (TTM)

OVID0.00x

PROK5.40x

Debt/Assets (TTM)

OVID0.0%

PROK0.0%

Interest Coverage (TTM)

OVIDN/A

PROKN/A

Net Debt/EBITDA (TTM)

OVID0.00x

PROK0.00x

Beta

OVID0.28

PROK1.95

52W Performance

OVID55.7%

PROK-46.6%

YTD Performance

OVID39.8%

PROK-22.0%

% from 52W High

OVID-20.8%

PROK-50.0%

% from 52W Low

OVID108.5%

PROK33.8%

Asset Turnover (TTM)

OVID0.01x

PROK0.00x

FCF Yield (TTM)

OVID-11.9%

PROK-30.4%

Earnings Yield (TTM)

OVID-7.5%

PROK-16.0%

Dividend Yield (TTM)

OVIDN/A

PROKN/A

Rule of 40

OVID-3,536.3

PROK-19,472.2

EV/GP/RG

OVIDN/A

PROKN/A

Ticker research

View OVID research View PROK research

Metric	OVID Ovid Therapeutics Inc	PROK Prokidney Corp
Market & Valuation
Market Cap	$459M	$526M
Enterprise Value	$448M	$451M
Price	$2.46	$1.74
P/E Ratio	N/A	N/A
P/S Ratio	290.04x	642.52x
EV/Sales	282.89x	551.08x
EV/EBITDA	3.65x	0.00x
P/B Ratio	2.21x	78.79x
P/FCF Ratio	N/A	N/A
EV/FCF	-8.18x	-2.82x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	1,284.26x	788.85x
Revenue & Growth
Revenue (TTM)	$2M	$818K
Revenue Growth (YoY)	-76.2%	55.2%
Forward Rev Growth	-72.6%	-44.4%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-3681.4%	-20827.6%
Net Margin (TTM)	-2178.9%	-10288.4%
FCF Margin (TTM)	-3460.1%	-19527.4%
Net Income (TTM)	$-34M	$-84M
FCF (TTM)	$-55M	$-160M
EPS (TTM)	-$0.17	-$0.45
ROE (TTM)	-2364.0%	-2810.2%
ROA (TTM)	-2052.0%	-2739.0%
ROIC (TTM)	-2364.0%	0.0%
Financial Health
Cash	$11M	$75M
Debt	$0	$67K
Net Cash/Debt	$11M	$75M
Current Ratio (TTM)	12.39x	8.36x
Quick Ratio (TTM)	11.75x	8.07x
Debt/Equity (TTM)	0.00x	5.40x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.28	1.95
52W Performance	55.7%	-46.6%
YTD Performance	39.8%	-22.0%
% from 52W High	-20.8%	-50.0%
% from 52W Low	108.5%	33.8%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-11.9%	-30.4%
Earnings Yield (TTM)	-7.5%	-16.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-3,536.3	-19,472.2
EV/GP/RG	N/A	N/A
Ticker research	View OVID research	View PROK research

Valuation

P/S Ratio

OVID

290.04x

PROK

642.52x

EV/FCF

OVID

-8.18x

PROK

-2.82x

Growth & revenue

Revenue Growth TTM

PROK

55.2%

OVID

-76.2%

Forward Revenue Growth

PROK

-44.4%

OVID

-72.6%

Profitability & performance

Gross Margin

OVID

0.0%

PROK

0.0%

ROE

OVID

-2364.0%

PROK

-2810.2%

FCF Yield %

OVID

-11.9%

PROK

-30.4%

52-Week Performance

OVID

55.7%

PROK

-46.6%

Detailed metrics comparison

OVID

Ovid Therapeutics Inc

PROK

Prokidney Corp

Market Cap

OVID$459M

PROK$526M

Enterprise Value

OVID$448M

PROK$451M

Price

OVID$2.46

PROK$1.74

P/E Ratio

OVIDN/A

PROKN/A

P/S Ratio

OVID290.04x

PROK642.52x

EV/Sales

OVID282.89x

PROK551.08x

EV/EBITDA

OVID3.65x

PROK0.00x

P/B Ratio

OVID2.21x

PROK78.79x

P/FCF Ratio

OVIDN/A

PROKN/A

EV/FCF

OVID-8.18x

PROK-2.82x

PEG Ratio

OVIDN/A

PROKN/A

Forward P/E (NTM)

OVIDN/A

PROKN/A

Forward P/S (NTM)

OVID1,284.26x

PROK788.85x

Revenue (TTM)

OVID$2M

PROK$818K

Revenue Growth (YoY)

OVID-76.2%

PROK55.2%

Forward Rev Growth

OVID-72.6%

PROK-44.4%

Gross Margin (TTM)

OVID0.0%

PROK0.0%

Operating Margin (TTM)

OVID0.0%

PROK0.0%

EBITDA Margin (TTM)

OVID-3681.4%

PROK-20827.6%

Net Margin (TTM)

OVID-2178.9%

PROK-10288.4%

FCF Margin (TTM)

OVID-3460.1%

PROK-19527.4%

Net Income (TTM)

OVID$-34M

PROK$-84M

FCF (TTM)

OVID$-55M

PROK$-160M

EPS (TTM)

OVID-$0.17

PROK-$0.45

ROE (TTM)

OVID-2364.0%

PROK-2810.2%

ROA (TTM)

OVID-2052.0%

PROK-2739.0%

ROIC (TTM)

OVID-2364.0%

PROK0.0%

Cash

OVID$11M

PROK$75M

Debt

OVID$0

PROK$67K

Net Cash/Debt

OVID$11M

PROK$75M

Current Ratio (TTM)

OVID12.39x

PROK8.36x

Quick Ratio (TTM)

OVID11.75x

PROK8.07x

Debt/Equity (TTM)

OVID0.00x

PROK5.40x

Debt/Assets (TTM)

OVID0.0%

PROK0.0%

Interest Coverage (TTM)

OVIDN/A

PROKN/A

Net Debt/EBITDA (TTM)

OVID0.00x

PROK0.00x

Beta

OVID0.28

PROK1.95

52W Performance

OVID55.7%

PROK-46.6%

YTD Performance

OVID39.8%

PROK-22.0%

% from 52W High

OVID-20.8%

PROK-50.0%

% from 52W Low

OVID108.5%

PROK33.8%

Asset Turnover (TTM)

OVID0.01x

PROK0.00x

FCF Yield (TTM)

OVID-11.9%

PROK-30.4%

Earnings Yield (TTM)

OVID-7.5%

PROK-16.0%

Dividend Yield (TTM)

OVIDN/A

PROKN/A

Rule of 40

OVID-3,536.3

PROK-19,472.2

EV/GP/RG

OVIDN/A

PROKN/A

Ticker research

View OVID research View PROK research

Metric	OVID Ovid Therapeutics Inc	PROK Prokidney Corp
Market & Valuation
Market Cap	$459M	$526M
Enterprise Value	$448M	$451M
Price	$2.46	$1.74
P/E Ratio	N/A	N/A
P/S Ratio	290.04x	642.52x
EV/Sales	282.89x	551.08x
EV/EBITDA	3.65x	0.00x
P/B Ratio	2.21x	78.79x
P/FCF Ratio	N/A	N/A
EV/FCF	-8.18x	-2.82x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	1,284.26x	788.85x
Revenue & Growth
Revenue (TTM)	$2M	$818K
Revenue Growth (YoY)	-76.2%	55.2%
Forward Rev Growth	-72.6%	-44.4%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-3681.4%	-20827.6%
Net Margin (TTM)	-2178.9%	-10288.4%
FCF Margin (TTM)	-3460.1%	-19527.4%
Net Income (TTM)	$-34M	$-84M
FCF (TTM)	$-55M	$-160M
EPS (TTM)	-$0.17	-$0.45
ROE (TTM)	-2364.0%	-2810.2%
ROA (TTM)	-2052.0%	-2739.0%
ROIC (TTM)	-2364.0%	0.0%
Financial Health
Cash	$11M	$75M
Debt	$0	$67K
Net Cash/Debt	$11M	$75M
Current Ratio (TTM)	12.39x	8.36x
Quick Ratio (TTM)	11.75x	8.07x
Debt/Equity (TTM)	0.00x	5.40x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.28	1.95
52W Performance	55.7%	-46.6%
YTD Performance	39.8%	-22.0%
% from 52W High	-20.8%	-50.0%
% from 52W Low	108.5%	33.8%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-11.9%	-30.4%
Earnings Yield (TTM)	-7.5%	-16.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-3,536.3	-19,472.2
EV/GP/RG	N/A	N/A
Ticker research	View OVID research	View PROK research